{"meta":{"query_hash":"4a42f9ea1204","filters":{"venue":"Journal of Pharmaceutical Research"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4a42f9ea1204","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Pharmaceutical+Research"},"results":[{"id":"W2738563879","doi":"10.18579/jpcrkc/2017/16/2/116432","title":"Drug Master File Filing in US, Europe, Canada and Australia","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Research","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Business; Medicine; Pharmacology","score_opus":0.38342138121012354,"score_gpt":0.4595554708074974,"score_spread":0.07613408959737389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738563879","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06202718,0.0054074475,0.005629557,0.02614119,0.0025258574,0.002929216,0.025249286,0.002941486,0.86714864],"genre_scores_gemma":[0.3494495,0.009696012,0.019821083,0.023916531,0.00071843213,0.0015874534,0.034283616,0.0030990038,0.5574283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96552783,0.002475694,0.0020194754,0.002448114,0.022578655,0.004950229],"domain_scores_gemma":[0.92862195,0.0058489214,0.0035655317,0.0037362673,0.05292184,0.0053053964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012431469,0.00048909127,0.000633257,0.006936943,0.006121449,0.009763529,0.0019257906,0.002218961,0.053274132],"category_scores_gemma":[0.05865678,0.0005008104,0.0009137266,0.0069985446,0.0024286313,0.00537396,0.0029734417,0.0023634026,0.019552032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005246839,0.00024127093,0.028154215,0.0010508054,0.00005389004,0.0007950935,0.0057604513,0.00058577425,0.002737864,0.09388395,0.65290165,0.21331039],"study_design_scores_gemma":[0.000054383596,0.00010031104,0.06853978,0.0007360777,0.000030649906,0.00058955787,0.003821543,0.00037727458,0.0023863665,0.0014441338,0.92178506,0.00013476792],"about_ca_topic_score_codex":0.5598211,"about_ca_topic_score_gemma":0.49593443,"teacher_disagreement_score":0.44017887,"about_ca_system_score_codex":0.030359335,"about_ca_system_score_gemma":0.07273229,"threshold_uncertainty_score":0.88554233},"labels":[],"label_agreement":null},{"id":"W4390679893","doi":"10.33140/jpr.08.02.07","title":"DPP4 valorphin activate NR4As pathway and OPA1 that protect from CoQ10 deficiency from OPA1 dysfunctions and from WMH","year":2023,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Research","topic":"Nuclear Receptors and Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Glial fibrillary acidic protein; Stroke (engine); Internal medicine; Medicine; Ischemic stroke; Gastroenterology; Ischemia; Immunohistochemistry","score_opus":0.37704025586133144,"score_gpt":0.4478709441495229,"score_spread":0.07083068828819145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390679893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931653,0.00250788,0.0015813737,0.00021873036,0.00009204725,0.000037378584,0.0006161803,0.00007612342,0.0017049699],"genre_scores_gemma":[0.9928335,0.0011503269,0.0012605318,0.000100554484,0.000018086977,0.000053320367,0.0006169888,0.00002247923,0.0039443197],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999343,0.0000092391465,0.000007039371,0.000011434093,0.000012305212,0.00002567683],"domain_scores_gemma":[0.99993014,0.000004329267,0.000024473766,0.000006950116,0.000007309015,0.00002680665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011463861,0.0003631775,0.0002479101,0.00027097345,0.00015959113,0.0002034392,0.00019181188,0.00023244688,0.0032062926],"category_scores_gemma":[0.00011744485,0.00011676648,0.00027377752,0.00008502856,0.00024372616,0.000161701,0.00020443808,0.0005754264,0.0003510309],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025261664,0.00016012575,0.0015363947,0.0001351819,0.00006329042,0.000356019,0.000024690355,0.00009062364,0.98766994,0.0002854534,0.00043032435,0.0067216647],"study_design_scores_gemma":[0.00039160275,0.0014760523,0.05023697,0.000047160534,0.0001586688,0.0020529353,0.00018148284,0.0010580819,0.93319297,0.0006528571,0.01053582,0.000015396221],"about_ca_topic_score_codex":0.0007956317,"about_ca_topic_score_gemma":0.0011960388,"teacher_disagreement_score":0.0032062926,"about_ca_system_score_codex":0.0002254819,"about_ca_system_score_gemma":0.00022200638,"threshold_uncertainty_score":0.010726094},"labels":[],"label_agreement":null}]}